Prediction of Major Depression and Dysthymia from CES-D Scores Among Ethnic Minority Adolescents
Overview
Authors
Affiliations
Objective: The Native Hawaiian Mental Health Research Development Program is an epidemiological longitudinal study of adolescents residing in Hawaii. This article examines the utility of the Center for Epidemiologic Studies-Depression Scale (CES-D) for predicting DSM-III-R diagnoses of major depression (MD) and dysthymic disorder (DD) and investigates whether prediction differs by gender and ethnicity.
Method: Diagnostic Interview Schedule for Children interviews were conducted with 556 adolescents randomly selected from among more than 7,000 students who had completed the CES-D.
Results: Six-month prevalence rates were as follows: MD = 8.5%, DD = 4.7%, either (MDDD) = 9.9%. Prevalence rates were significantly higher among females, but after CES-D scores were accounted for, gender no longer predicted depression in most analyses. When a cutoff score of 16 was used, classification accuracy was lower for Native Hawaiians than non-Hawaiians. However, after group differences in gender and grade level were accounted for, the predictive validity of the CES-D did not differ by ethnicity. CES-D factor 1 scores identified MD, DD, and MDDD about as well as the total score or all three factors together.
Conclusions: These results support the validity of the CES-D for screening for depression among adolescents of Native Hawaiian and other minority backgrounds.
Wallbing U, Nilsson S, Lundberg M, Wigert H, Kemani M Front Pain Res (Lausanne). 2023; 4:1264355.
PMID: 38034879 PMC: 10682372. DOI: 10.3389/fpain.2023.1264355.
Wood B, Cubbin C, Rubalcava Hernandez E, DiNitto D, Vohra-Gupta S, Baiden P Int J Environ Res Public Health. 2023; 20(19).
PMID: 37835154 PMC: 10572337. DOI: 10.3390/ijerph20196884.
Park S, Kwon Y Child Psychiatry Hum Dev. 2023; .
PMID: 37354303 DOI: 10.1007/s10578-023-01553-6.
Exercise and epigenetic ages in older adults with myeloid malignancies.
Loh K, Sanapala C, Jensen-Battaglia M, Rana A, Sohn M, Watson E Eur J Med Res. 2023; 28(1):180.
PMID: 37254221 PMC: 10227405. DOI: 10.1186/s40001-023-01145-z.
Loh K, Sanapala C, Watson E, Jensen-Battaglia M, Janelsins M, Klepin H Blood Adv. 2022; 6(13):3850-3860.
PMID: 35320340 PMC: 9278283. DOI: 10.1182/bloodadvances.2022007056.